Sign Up Today and Learn More About ARTBIO Stock
Invest in or calculate the value of your shares in ARTBIO or other pre-IPO companies through EquityZen's platform.
ARTBIO Stock
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
About ARTBIO Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
ARTBIO Press Mentions
Stay in the know about the latest news on ARTBIO
Top 10 Startup and Tech Funding News – July 31, 2025
techstartups • Aug 01, 2025
KuCoin invests in Stable, a blockchain startup built for USDT to reinvent global stablecoin payments
techstartups • Aug 01, 2025
Top jobs most at risk of being replaced by AI, according to Microsoft
techstartups • Aug 01, 2025
Financings for July 30, 2025
bioworld • Jul 31, 2025
White House set to unveil closely watched crypto policy report
zawya • Jul 30, 2025
ARTBIO Management
Leadership team at ARTBIO
Chief Scientific Officer
Nick Pullen
Board Member
Jeffrey Tong
Join now and verify your accreditation status to gain access to:
- ARTBIO Current Valuation
- ARTBIO Stock Price
- ARTBIO Management
- Available deals in ARTBIO and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- ARTBIO Cap Table and Funding History by Share Class and Liquidity Preferences
- ARTBIO Revenue and Financials
- ARTBIO Highlights
- ARTBIO Business Model
- ARTBIO Risk Factors
- ARTBIO Research Report from SACRA Research
Trading ARTBIO Stock
How to invest in ARTBIO stock?
Accredited investors can buy pre-IPO stock in companies like ARTBIO through EquityZen funds. These investments are made available by existing ARTBIO shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ARTBIO stock?
Shareholders can sell their ARTBIO stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."